loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Nateglinide

    Menu

    Nateglinide

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 342Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21204 / DOSAGE - TABLET;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    NATEGLINIDE(UNII: 41X3PWK4O2)
    (NATEGLINIDE - UNII:41X3PWK4O2)     		NATEGLINIDE60mg | 120mg

    Inactive Ingredients

    Ingredient Name
    Novartis Pharmaceuticals Corporation
    CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
    CROSCARMELLOSE SODIUM(M28OL1HH48)
    FERRIC OXIDE RED(1K09F3G675)
    FERRIC OXIDE YELLOW(EX438O2MRT)
    HYPROMELLOSE 2208 (15000 MPA.S)(Z78RG6M2N2)
    LACTOSE MONOHYDRATE(EWQ57Q8I5X)
    MAGNESIUM STEARATE(70097M6I30)
    POLYETHYLENE GLYCOL(3WJQ0SDW1A)
    POVIDONE(FZ989GH94E)
    SILICON DIOXIDE(ETJ7Z6XBU4)
    TALC(7SEV7J4R1U)
    TITANIUM DIOXIDE(15FIX9V2JP)